Futura Medical (LON:FUM) Posts Quarterly Earnings Results

Futura Medical (LON:FUM) released its quarterly earnings data on Tuesday. The company reported GBX (0.20) earnings per share for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%.

Futura Medical Stock Down 1.8%

Shares of LON FUM traded down GBX 0.01 during midday trading on Tuesday, reaching GBX 0.37. 22,394,688 shares of the company’s stock traded hands, compared to its average volume of 9,153,882. The stock’s 50 day simple moving average is GBX 0.43 and its 200-day simple moving average is GBX 0.80. Futura Medical has a one year low of GBX 0.24 and a one year high of GBX 10.45. The company has a market cap of £2.17 million, a price-to-earnings ratio of -0.13 and a beta of 0.02.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.